Atlas FDA

APTIMA HPV ASSAY

FDA premarket approval P100042 · decided 2011-10-28

Approval details

PMA number
P100042
Trade name
APTIMA HPV ASSAY
Generic name
Kit, rna detection, human papillomavirus
Applicant
Gen-Probe Incorporated
Date received
2010-11-05
Decision date
2011-10-28
Days to decision
357 days
Decision code
APPR
Product code
OYB
Advisory committee
Microbiology
Expedited review
No
Location
San Diego, CA
Statement
APPROVAL FOR THE APTIMA HPV ASSAY.APTIMA HPV ASSAY INDICATIONS FOR USE:THE APTIMA HPV ASSAY IS AN IN VITRO NUCLEIC ACID AMPLIFICATION TEST FOR THE QUALITATIVE DETECTIONOFE6/E7 VIRAL MESSENGER RNA (MRNA) FROM 14 HIGH-RISK TYPES OF HUMAN PAPILLOMAVIRUS (HPV) IN CERVICAL SPECIMENS. THE HIGH-RISK HPV TYPES DETECTED BY THE ASSAY INCLUDE: 16, 18,31,33,35, 39,45,51,52,56,58,59,66, AND 68. THE APTIMA HPV ASSAY DOES NOT DISCRIMINATE BETWEEN THE14 HIGH-RISK TYPES. CERVICAL SPECIMENS IN THINPREP PAP TEST V

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
APTIMA TRICHOMONAS VAGINALIS ASSAY (DEN110012)Gen-Probe Incorporated2011-04-19